|
" Antioxidants and Cardiovascular Disease "
edited by Jean-Claude Tardif, Martial G. Bourassa.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
775353
|
| Doc. No
|
:
|
b595348
|
| Main Entry
|
:
|
edited by Jean-Claude Tardif, Martial G. Bourassa.
|
| Title & Author
|
:
|
Antioxidants and Cardiovascular Disease\ edited by Jean-Claude Tardif, Martial G. Bourassa.
|
| Publication Statement
|
:
|
Dordrecht : Springer Netherlands, 2000
|
| Series Statement
|
:
|
Developments in cardiovascular medicine, 233.
|
| Page. NO
|
:
|
(xii, 258 pages)
|
| ISBN
|
:
|
9401143757
|
|
|
:
|
: 9789401143752
|
| Contents
|
:
|
1. Lipoproteins and Oxidation: Clinical Aspects of Lipoprotein Metabolism and Oxidation --; 2. Pathogenesis of Artherosclerosis --; 3. The Antioxidant Hypothesis --; 4. Reactive Oxygen Species as Mediators of Signal Transduction in Cardiovascular Disease --; 5. Pharmaceutical Compounds with Antioxidant Activity --; 6. Nutrition and Antioxidants --; 7. Antioxidants and Vascular Disease: Animal Studies --; 8. Antioxidants and Endothelial Function --; Human Studies --; 9. Antioxidant Vitamins and Cardiovascular Disease: Evidence from Observational Epidemiologic Studies and Randomized Trials --; 10. A Rationale for Antioxidant Use in Cardiovascular Disease --; 11. Antioxidants and Restenosis --; Animal Studies --; 12. Antioxidants and Restenosis --; Human Studies --; 13. Role of Oxidative Stress, Cytokines and Apoptosis in Myocardial Dysfunction --; 14. Oxidative Stress and Use of Antioxidants in Patients with Congestive Heart Failure --; 15. Use of Antioxidants in Cardiovascular Medicine --; Appendix Update on Recently Completed Clinical Trials on Antioxidants and Cardiovascular Diseases.
|
| Abstract
|
:
|
This book addresses a complex but very timely and fascinating problem in cardiovascular medicine. It is written by recognized experts in the fields of atherosclerosis, heart failure, and antioxidants. It should be of interest not only to academicians but to practising physicians, including postdoctoral fellows, internists, cardiologists, and general practitioners. The first three chapters review the antioxidant hypothesis and its close relationship to lipid metabolism and pathogenesis of atherosclerosis. The subsequent chapters define the mechanisms of action and classify the different and heterogeneous pharmacological compounds with known antioxidant properties, and describe the role of dietary nutrients and supplements as well as the potential therapeutic benefit of antioxidants in coronary artery disease prevention and risk reduction, prevention of endothelial dysfunction, and prevention of coronary restenosis after percutaneous coronary interventions and treatment and prevention of chronic heart failure. Finally, current knowledge of the use of these compounds in cardiovascular medicine is summarized.
|
| Subject
|
:
|
Cardiology.
|
| Subject
|
:
|
Medicine.
|
| Subject
|
:
|
Nutrition.
|
| LC Classification
|
:
|
RC669.9E358 2000
|
| Added Entry
|
:
|
Jean-Claude Tardif
|
|
|
:
|
Martial G Bourassa
|
| |